LCN2 has been shown to inhibit tumor angiogenesis by suppressing RAS-induced VEGF expression in 4 T1 tumor cells[20], but to increase angiogenesis in a different breast cancer model[21]. This evidence concerns the gene VEGFA and neoplasm.